• Exchange: OTC BB
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Titan Pharmaceuticals Inc

+ Add to Watchlist

TTNP:US

0.6200 USD 0.0200 3.33%

As of 20:10:00 ET on 04/24/2014.

Snapshot for Titan Pharmaceuticals Inc (TTNP)

Open: 0.6000 Day's Range: 0.5901 - 0.6200 Volume: 195,497
Previous Close: 0.6000 52wk Range: 0.3200 - 1.8300 1-Yr Rtn: -64.37%

Stock Chart for TTNP

No chart data available.
  • TTNP:US 0.6200
  • 1D
  • 1M
  • 1Y
0.6000
Interactive TTNP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTNP

Current P/E Ratio (ttm) 10.3333
Estimated P/E(12/2014) -
Relative P/E vs. SPX 0.6012
Earnings Per Share (USD) (ttm) 0.0600
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 55.21
Shares Outstanding (M) 89.05
30 Day Average Volume 140,286
Price/Book (mrq) 50.0758
Price/Sale (ttm) 4.7657
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTNP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TTNP

Titan Pharmaceuticals, Inc. is a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. The company is also developing gene therapy and drug delivery technologies.

Marc RubinChairmanSunil BhonslePresident
More Company Profile & Key Executives for TTNP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil